The 2026 Healthtech Messaging Index
Xsolis
xsolis.com·scored August 23, 2026
19/38
Invisible
The page is doing some work, but the story isn't landing fast enough. Buyers and AI are both left guessing what makes Xsolis different.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for AI-powered utilization management and medical necessity decision support software for hospitals, it named:
Buyer we put in the prompt: VP of Revenue Integrity, Chief Medical Officer, or Director of Utilization Management at a hospital or health system. Both the buyer and the category were inferred from Xsolis’s homepage alone. The model had no web access.
Xsolis was on the list.
AI named them for their own category. That's the signal every homepage is supposed to send.
AI mentioned you for "AI-powered utilization management and medical necessity decision support software for hospitals", but only generically: "Xsolis offers an AI-driven platform called Dragonfly focused on utilization management and medical necessity, helping hospitals reduce denials and align clinical documentation with payer expectations.". You're on the radar, but AI doesn't yet repeat your specific positioning back.
Overall assessment
Xsolis's biggest strength is its trust stack ... concrete ROI numbers above the fold, five consecutive KLAS #1 rankings, peer-reviewed academic validation, and named testimonials from recognizable health systems combine to create unusually credible social proof for a niche B2B healthcare platform. The biggest gap is a complete absence of problem leadership and cost-of-inaction narrative: the page never tells the buyer what is broken today or what it costs them to do nothing, which means it reads as a feature catalog rather than a compelling case for change.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
02Rebellion / Movement
“No named enemy, status quo critique, or industry pattern called out anywhere on the page.”
The page never names a broken system, a failed alternative, or an industry pattern it opposes; it presents features and benefits with no missionary point of view.
All 19 signals, scored 0 to 2.
Total 19/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“Better Mid-Cycle Outcomes, Powered by Intelligent Insights”
The hero headline is jargon-heavy ('mid-cycle,' 'intelligent insights') and requires healthcare industry knowledge to decode; a stranger cannot instantly identify who this is for or what problem it solves without reading the subhead.
- 0
02Rebellion / Movementweakest
“No named enemy, status quo critique, or industry pattern called out anywhere on the page.”
The page never names a broken system, a failed alternative, or an industry pattern it opposes; it presents features and benefits with no missionary point of view.
- 1
03Owned Language & Category
“Dragonfly delivers insight-driven workflows that reduce friction, protect revenue, and align providers and payers”
'Dragonfly' is a named product and 'mid-cycle' is a claimed frame, but neither constitutes an owned category or coined term that AI would uniquely attribute to Xsolis over competitors.
- 1
04ICP Clarity
“For Hospitals & Health Systems" and "For Health Plans & More”
Buyer segments are named but only at a high level; roles like UR nurses, utilization managers, and case managers appear mid-page but are not prominent in the hero, and company size or stage is never specified.
- 0
05Problem Leadership
“Better Mid-Cycle Outcomes, Powered by Intelligent Insights”
The page opens with a solution-and-outcome statement, not with the buyer's problem in their language; the pain (denials, fragmented data, manual burden) only surfaces in body copy well below the fold.
- 1
06Solution Clarity
“Streamline medical necessity decisions, discharge planning, and payer-provider collaboration while actively preventing denials.”
The subhead gives a passable one-sentence explanation of what Dragonfly does, but it lists four things at once and the verb 'streamline' is generic, making it hard to repeat with confidence.
- 0
07Cost of Inaction
“No explicit cost-of-inaction statement anywhere on the page.”
The page never names what happens if a hospital keeps its current process ... no lost revenue figure, no denial rate worsening, no staff burnout consequence ... so stakes are absent.
- 1
08Promised Land
“transforming data into measurable outcomes, not just documentation”
There is a hint of an 'after' state (measurable outcomes, sustained financial improvement) but it remains abstract rather than painting a specific, vivid life the buyer will live post-adoption.
Trust Signal
4 signals
- 2
09Proof & Evidence
“5x-7x Average Customer ROI" ">9.5B Predictions and Growing" "615+ Hospitals" "95% Client Retention Rate”
Multiple concrete, quantified numbers appear above the fold and are specific enough to signal real outcomes rather than adjective-only claims.
- 2
10Social Proof
“- Michele Greame, AVP of Revenue Integrity, Inova Health System”
Named logos of recognizable health systems (Mayo Clinic, AdventHealth, BSW), a named testimonial with full title and organization, and linked case studies together constitute strong social proof.
- 2
11Authority & Credibility
“KLAS Award 2025" "#1 Physician Advisory Services" fifth consecutive year; peer-reviewed studies cited”
Five consecutive KLAS #1 rankings, multiple named industry awards, and peer-reviewed academic validation constitute demonstrated ... not merely claimed ... authority.
- 0
12Alternatives Acknowledged
“No mention of competitors, alternative approaches, or 'do nothing' option anywhere on the page.”
The page never acknowledges that buyers have other options, which is a missed trust signal and leaves the competitive context entirely unaddressed.
AI Signal
6 signals
- 1
13Customer Focus
“Xsolis partners with your team beyond implementation by providing ongoing performance monitoring”
The page mixes customer outcomes with company capability descriptions; the protagonist tilts toward Xsolis and Dragonfly rather than consistently centering the customer's transformation.
- 1
14AI-Parmesan Index
“Dragonfly uses artificial intelligence to streamline mid-revenue cycle workflows and unify real-time clinical data”
AI is invoked but the mechanism is only partially explained ('reveals patterns and predictions'); it avoids pure AI-Parmesan sprinkling but stops short of the mechanistic specificity that would earn a 2.
- 1
15LLM Quotability
“a more dynamic and data-driven approach to determining medical necessity...streamline decision-making and allows clinicians to focus their time where their expertise is most impactful”
The Inova testimonial is quotable but is a customer quote, not a clean declarative company claim; Xsolis's own copy is wordy and clause-heavy, making it hard for an LLM to lift a crisp citation.
- 2
16Copyright Freshness
“2026 in health care, AI: Trends facing an industry at a crossroads" and image paths containing '/2026/04/'”
Multiple content items reference 2026 dates, press releases and blog posts are dated 2026, and award images carry 2026 timestamps, signaling fresh and current content.
- 1
17Entity Distinctiveness
“Purpose-built to see what others miss" and "A dragonfly processes thousands of signals at once. So does Dragonfly.”
The dragonfly metaphor and KLAS #1 ranking provide some distinctiveness, but the core description of AI-driven utilization management workflows is not unique enough that an AI could not apply it to a competitor.
- 1
18AI Recommendation Check
“AI named you alongside Interqual (Change Healthcare/Optum), Milliman Care Guidelines (MCG Health), Utilization Management AI by Olive, Medscape/Wolters Kluwer UpToDate, Xsolis, describing you as: "Xsolis offers an AI-driven platform called Dragonfly focused on utilization management and medical necessity, helping hospitals reduce denials and align clinical documentation with payer expectations.".”
AI mentioned you for "AI-powered utilization management and medical necessity decision support software for hospitals", but only generically: "Xsolis offers an AI-driven platform called Dragonfly focused on utilization management and medical necessity, helping hospitals reduce denials and align clinical documentation with payer expectations.". You're on the radar, but AI doesn't yet repeat your specific positioning back.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“SEE HOW IT WORKS" and "SEE DRAGONFLY IN ACTION" both linking to /consult-request/”
There is a primary CTA repeated twice but no soft secondary CTA (e.g., download, watch demo inline) and no numbered steps or visible process, so the path is incomplete.
Keep the lead
AI already names Xsolis. The next edition decides if it still does.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Xsolis the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.